Wang E
Wang E (; 1465? – 1545) was an imperial landscape painter during the Ming dynasty.Wang E, style name 'Tingzhi' (廷直), was born in Fenghua, Zhejiang. He studied under Xiao Feng and later he served the Hongzhi Emperor. The emperor praised him as the Ma Yuan of his day (今之馬遠). Among the paintings of his that can be definitively dated, two were for Japanese envoys. He later retired to teaching and died at age 80. Provided by Wikipedia
Showing 1 - 20 results of 22 for search 'Wang E', query time: 0.32s
Refine Results
-
1
Tight metabolic coupling of the proteasome with downstream oligopeptidases. by Wang, E, Kessler, B, Barodovsky, A, Ploegh, H
Published 1999Journal article -
2
-
3
Circ_0040929 Serves as Promising Biomarker and Potential Target for Chronic Obstructive Pulmonary Disease by Miao Y, Wu J, Wu R, Wang E, Wang J
Published 2022-09-01
Article -
4
Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR. by Lawson, T, Man, S, Wang, E, Williams, S, Amos, N, Gillespie, G, Moss, P, Borysiewicz, L
Published 2001Journal article -
5
Multiscale gyrokinetics for rotating tokamak plasmas: fluctuations, transport and energy flows. by Abel, I, Plunk, G, Wang, E, Barnes, M, Cowley, S, Dorland, W, Schekochihin, A
Published 2013Journal article -
6
Machine learning and primary total knee arthroplasty: patient forecasting for a patient-specific payment model by Navarro, S, Wang, E, Haeberle, H, Mont, M, Krebs, V, Patterson, B, Ramkumar, P
Published 2018Journal article -
7
Regional Analgesia for Cesarean Delivery: A Narrative Review Toward Enhancing Outcomes in Parturients by Silverman M, Zwolinski N, Wang E, Lockwood N, Ancuta M, Jin E, Li J
Published 2023-11-01
Article -
8
Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. by Wang, E, Kessler, B, Borodovsky, A, Cravatt, B, Bogyo, M, Ploegh, H, Glas, R
Published 2000Journal article -
9
Lack of annexin 1 results in an increase in corticotroph number in male but not female mice. by Morris, J, Omer, S, Davies, E, Wang, E, John, C, Afzal, T, Wain, S, Buckingham, J, Flower, R, Christian, H
Published 2006Journal article -
10
Functional proteomics of the active cysteine protease content in Drosophila S2 cells. by Kocks, C, Maehr, R, Overkleeft, H, Wang, E, Iyer, L, Lennon-Dumenil, A, Ploegh, H, Kessler, B
Published 2003Journal article -
11
A porphyrin pentamer as a bright emitter for NIR OLEDs by Tejerina, L, Rapidis, AG, Rickhaus, M, Murto, P, Genene, Z, Wang, E, Minotto, A, Anderson, HL, Cacialli, F
Published 2022Journal article -
12
-
13
SDSS-IV MaNGA: the indispensable role of bars in enhancing the central star formation of low-z galaxies by Lin, L, Li, C, Du, C, Wang, E, Xiao, T, Bureau, M, Fraser-McKelvie, A, Masters, K, Lin, L, Wake, D, Hao, L
Published 2020Journal article -
14
Evidence for metastable photo-induced superconductivity in K3C60 by Budden, M, Gebert, T, Buzzi, M, Jotzu, G, Wang, E, Matsuyama, T, Meier, G, Laplace, Y, Pontiroli, D, Ricco, M, Schlawin, F, Jaksch, D, Cavalleri, A
Published 2021Journal article -
15
Biowire model of interstitial and focal cardiac fibrosis by Wang, E, Rafatian, N, Zhao, Y, Lee, A, Lai, B, Lu, R, Jekic, D, Davenport Huyer, L, Knee-Walden, E, Bhattacharya, S, Backx, P, Radisic, M
Published 2019Journal article -
16
-
17
-
18
Transgenic Drosophila lines for LexA-dependent gene and growth regulation by Chang, KR, Tsao, DD, Bennett, C, Wang, E, Floyd, JF, Tay, ASY, Greenwald, E, Kim, ES, Griffin, C, Morse, E, Chisholm, T, Rankin, AE, Baena-Lopez, LA, Lantz, N, Fox, E, Kockel, L, Kim, SK, Park, S
Published 2022Journal article -
19
AML-464 Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline patients with TP53-mutated acute myeloid leukemia (AML)... by Daver, N, Vyas, P, Kambhampati, S, Malki, MA, Larson, R, Asch, A, Mannis, G, Chai-Ho, W, Tanaka, T, Bradley, T, Jeyakumar, D, Wang, E, Xing, G, Chao, M, Ramsingh, G, Renard, C, Lal, I, Zeidner, J, Sallman, D
Published 2022Conference item -
20
MDS-445 Magrolimab in combination with azacitidine for patients with untreated higher-risk myelodysplastic syndromes (HR MDS): 5F9005 phase 1b study results by Sallman, D, Malki, MA, Asch, A, Wang, E, Jurcic, J, Bradley, T, Flinn, I, Pollyea, D, Kambhampati, S, Tanaka, T, Zeidner, J, Garcia-Manero, G, Jeyakumar, D, Gu, L, Tan, A, Chao, M, O'Hear, C, Lal, I, Vyas, P, Daver, N
Published 2022Conference item